Bioequivalence assessment of the two brands of glimepiride tablets

Background/Aim. Glimepiride, as an antidiabetic from the group of sulfonylurea, is administered perorally in the treatment of diabetes mellitus. The aim of this study was to compare pharmacokinetic profiles and relative bioavailabilities of the two oral formulations of glimepiride, generic and innov...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Jovanović Dušan, Stojšić Dragan, Zlatković Milica, Jović-Stošić Jasmina, Jovanović Miodrag
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	Ministry of Defence of the Republic of Serbia, University of Defence, Belgrade 2006-01-01
Σειρά:	Vojnosanitetski Pregled
Θέματα:	diabetes mellitus, type 2 drugs, generic sulfonylurea compounds therapeutic equivalency biological availability
Διαθέσιμο Online:	http://www.doiserbia.nb.rs/img/doi/0042-8450/2006/0042-84500612015J.pdf
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!